Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Comparison of Outcomes between Haploidentical and Matched Related Donors for Chronic Myelomonocytic Leukemia: A Multicenter Real-World Study

Blood (2024) 144 (Supplement 1): 2187.

https://doi.org/10.1182/blood-2024-206919

Published: 2024

Journal Articles

Evaluating Treatment-Related Outcomes in the Era of Targeted Therapy for Rosai Dorman and Erdheim Chester Disease

Sabrina R Wilcox, XI Yang, Asra Z. Ahmed, Samuel B Reynolds

Blood (2024) 144 (Supplement 1): 3911.

https://doi.org/10.1182/blood-2024-206397

Published: 2024

Journal Articles

High Prevalence of Concomitant Autoimmunity in Patients with Rosai-Dorfman Disease

Mitali Sen, Gordon J Ruan, Samuel B Reynolds, Haadi Ali, XI Yang, Diana Morlote, Aishwarya Ravindran, Lauren Kelly Shea, Matthew J Koster, Jithma P Abeykoon, Hind Salama, Xinxin Cao, Asra Z. Ahmed, Ronald S Go, Gaurav Goyal

Blood (2024) 144 (Supplement 1): 3910.

https://doi.org/10.1182/blood-2024-201817

Published: 2024

Journal Articles

Risk Factors for Severe Infection in Patients Receiving Bispecific Antibody Therapies for Lymphoma

Iman Ahmed, Victoria Nachar, Lydia Benitez, Shannon A. Carty, Dahlia Sano, Ryan A. Wilcox, XI Yang, Jonathan Weiss, Yasmin H. Karimi

Blood (2024) 144 (Supplement 1): 3105.

https://doi.org/10.1182/blood-2024-205406

Published: 2024

Journal Articles

Risk Factors for Cytokine Release Syndrome in Patients Receiving Bispecific Antibodies for B-Cell Lymphoma: A Single-Center, Retrospective Cohort Study

XI Yang, Iman Ahmed, Victoria Nachar, Shannon A. Carty, Ryan A. Wilcox, Jonathan Weiss, Dahlia Sano, Tycel J. Phillips, Yasmin H. Karimi

Blood (2024) 144 (Supplement 1): 4477.

https://doi.org/10.1182/blood-2024-211076

Published: 2024

Journal Articles

Real-World Outcomes with Bispecific T-Cell Engagers (REALBiTE) for Relapsed or Refractory Large B-Cell Lymphoma: A Multi-Center, Retrospective Cohort Study

Blood (2024) 144 (Supplement 1): 111.

https://doi.org/10.1182/blood-2024-199330

Published: 2024

Journal Articles

Exploring Prognostic Factors of Venetoclax Combined with Azacitidine in Unfit AML Based on Real-World Data from a Chinese Population

Boyue Zheng, FU JIyi, Jiafei Wu, Wang Yu, Jun Wang, Chuanyan Jiang, Wang Huan, Yang Haiqing, Xi Yang, Hong Zheng, Li Hui

Blood (2024) 144 (Supplement 1): 5948.

https://doi.org/10.1182/blood-2024-205623

Published: 2024

Journal Articles

Targeted Sequencing in Rosai-Dorfman Disease from Microdissected Specimens Reveals Higher Incidence of MAP2K1 Mutations

Andrew L Valesano, Samuel B Reynolds, Sabrina R Wilcox, XI Yang, Haadi Ali, Asra Z. Ahmed, Noah Brown

Blood (2024) 144 (Supplement 1): 6560.

https://doi.org/10.1182/blood-2024-209478

Published: 2024

Journal Articles

Efficacy and Safety of Dose-Tailored Mitoxantrone Liposomes Combined with Cytarabine and Venetoclax in Newly Diagnosed Acute Myeloid Leukemia (Non-M3) Based on Marrow Leukemic Cellularity

Li Hui, FU JIyi, Boyue Zheng, Lianjie HU, Yaqiong LI, Xin WANG, Qing HU, Li Wei, Hai Yi, Ying Yuan, Wang Huan, Yang Haiqing, Xi Yang, Hong Zheng, Yongqian Jia

Blood (2024) 144 (Supplement 1): 6068.

https://doi.org/10.1182/blood-2024-203401

Published: 2024

Journal Articles

Data of Daratumumab from a Real-World Single-Center Study

Jun Wang, Jiafei Wu, Xi Yang, Hong Zheng, Yijing Wang, Boyue Zheng, Feiyang Li, Hui Li

Blood (2022) 140 (Supplement 1): 12650.

https://doi.org/10.1182/blood-2022-170588

Published: 2022

Journal Articles

Single Center Experience of " Mobilize，Collect and Transplant, No Cryopreservation" Integrated Autologous Hematopoietic Stem Cells Transplantation Strategy for Newly Diagnosed Multiple Myeloma

Xi Yang, Chenglong Li, Feifei Che, Hong Zheng, Jiao Chen, Xiaobing Huang

Blood (2022) 140 (Supplement 1): 12930.

https://doi.org/10.1182/blood-2022-168915

Published: 2022

Journal Articles

Leonurine Promotes the Maturation of Healthy Donors and Multiple Myeloma Patients Derived-Dendritic Cells

Cheng Chen, Lin He, Xi Wang, Zichen Ye, Rong Xiao, Hong Zheng, Shu Chen, Hui Li, Xi Yang, Xuemei Wang, Yu Wang, Xuemei Ye, Xiaobing Huang, Jingying Dai

Blood (2022) 140 (Supplement 1): 12439.

https://doi.org/10.1182/blood-2022-157665

Published: 2022

Journal Articles

High-Dose Intravenous Acyclovir Is Safe and Effective in the Treatment of EBV Reactivation Post Allogeneic Hematopoietic Stem Cell Transplantation

Yu Wang, Xuemei Ye, Hong Zheng, Yan Mao, Xuemei Wang, Feifei Che, Chunsen Wang, Xi Yang, Xiaobing Huang

Blood (2021) 138 (Supplement 1): 4863.

https://doi.org/10.1182/blood-2021-149569

Published: 2021

Journal Articles

Prevalence and Risk Factor for Hepatocellular Carcinoma in Individuals with Hemophilia in the Era of Direct-Acting Antiviral Agents: A National Inpatient Sample Study

XI Yang, Kwonho Jeong, Jonathan G. Yabes, Margaret V. Ragni

Blood (2021) 138 (Supplement 1): 593.

https://doi.org/10.1182/blood-2021-151713

Published: 2021

Journal Articles

This Is a Title: Single-Center Data Report of Clhag Regimen for R/R-AML Patients

Chuanyan Jiang, Yu Wang, Mengying Zou, Yijing Wang, Jun Wang, Jiafei Wu, Xi Yang, Hui LI, MD

Blood (2020) 136 (Supplement 1): 3.

https://doi.org/10.1182/blood-2020-139708

Published: 2020

Journal Articles

This Is a Title: Cytarabine Combined with PD-1 Inhibitor in the Treatment of R/R-AML: A Report of 3 Cases and Literature Review

Yu Wang, Chuanyan Jiang, Xi Yang, Jingying Dai, PhD, Mengying Zou, Yijing Wang, Jun Wang, Jiafei Wu, Hui LI, MD

Blood (2020) 136 (Supplement 1): 26.

https://doi.org/10.1182/blood-2020-139729

Published: 2020

Journal Articles

Assay Specificity and Sensitivity Evaluation of Cepheid GeneXpert ® NPM1 Prototype for Mutation Detection in Acute Myeloid Leukemia

Xi Yang, PhD, Krupa Shridhar, Jayashree Sanjeeviraman, Gwo-Jen Day, PhD

Blood (2020) 136 (Supplement 1): 27–28.

https://doi.org/10.1182/blood-2020-140809

Published: 2020

Journal Articles

Dasatinib Promotes the Maturation of Healthy Donors and Chronic Myelogenous Leukemia Patients Derived Dendritic Cells

Wangjun Cao, Lin He, Hong Zheng, MDPhD, Xiaobing Huang, Xi Yang, Xiaodong WANG, MD, Jingying Dai, PhD

Blood (2020) 136 (Supplement 1): 53–54.

https://doi.org/10.1182/blood-2020-138462

Published: 2020

Journal Articles

Long-Term Follow-up of Hematopoietic Stem Cell Transplantation with the Modified Peking Regimen for the Treatment of Acute Leukemia

Xi Yang, Chenglong Li, MDand PhD, Rong Zhang, MDand PhD, Hong Zheng, MD PhD, Qing Wei, MD PhD, Chunsen Wang, MD, Jingying Dai, PhD, Xiaobing Huang, Ningning Tang

Blood (2019) 134 (Supplement_1): 2034.

https://doi.org/10.1182/blood-2019-124419

Published: 2019

Journal Articles

Dose-Adjusted Granulocyte Colony-Stimulating Factor Plus Dexamethasone Achieves More CD34+ Cell Mobilization and Earlier Engraftment in Haploidentical Hematopoietic Stem Cell Transplantation

Chenglong Li, MDand PhD, Xi Yang, Jingying Dai, PhD, Ningning Tang, Hong Zheng, MD PhD, Chunsen Wang, MD, Xiaobing Huang

Blood (2019) 134 (Supplement_1): 1966.

https://doi.org/10.1182/blood-2019-126632

Published: 2019

NARROW

Comparison of Outcomes between Haploidentical and Matched Related Donors for Chronic Myelomonocytic Leukemia: A Multicenter Real-World Study

Evaluating Treatment-Related Outcomes in the Era of Targeted Therapy for Rosai Dorman and Erdheim Chester Disease

High Prevalence of Concomitant Autoimmunity in Patients with Rosai-Dorfman Disease

Risk Factors for Severe Infection in Patients Receiving Bispecific Antibody Therapies for Lymphoma

Risk Factors for Cytokine Release Syndrome in Patients Receiving Bispecific Antibodies for B-Cell Lymphoma: A Single-Center, Retrospective Cohort Study

Real-World Outcomes with Bispecific T-Cell Engagers (REALBiTE) for Relapsed or Refractory Large B-Cell Lymphoma: A Multi-Center, Retrospective Cohort Study

Exploring Prognostic Factors of Venetoclax Combined with Azacitidine in Unfit AML Based on Real-World Data from a Chinese Population

Targeted Sequencing in Rosai-Dorfman Disease from Microdissected Specimens Reveals Higher Incidence of MAP2K1 Mutations

Efficacy and Safety of Dose-Tailored Mitoxantrone Liposomes Combined with Cytarabine and Venetoclax in Newly Diagnosed Acute Myeloid Leukemia (Non-M3) Based on Marrow Leukemic Cellularity

Data of Daratumumab from a Real-World Single-Center Study

Single Center Experience of " Mobilize，Collect and Transplant, No Cryopreservation" Integrated Autologous Hematopoietic Stem Cells Transplantation Strategy for Newly Diagnosed Multiple Myeloma

Leonurine Promotes the Maturation of Healthy Donors and Multiple Myeloma Patients Derived-Dendritic Cells

High-Dose Intravenous Acyclovir Is Safe and Effective in the Treatment of EBV Reactivation Post Allogeneic Hematopoietic Stem Cell Transplantation

Prevalence and Risk Factor for Hepatocellular Carcinoma in Individuals with Hemophilia in the Era of Direct-Acting Antiviral Agents: A National Inpatient Sample Study

This Is a Title: Single-Center Data Report of Clhag Regimen for R/R-AML Patients

This Is a Title: Cytarabine Combined with PD-1 Inhibitor in the Treatment of R/R-AML: A Report of 3 Cases and Literature Review

Assay Specificity and Sensitivity Evaluation of Cepheid GeneXpert ® NPM1 Prototype for Mutation Detection in Acute Myeloid Leukemia

Dasatinib Promotes the Maturation of Healthy Donors and Chronic Myelogenous Leukemia Patients Derived Dendritic Cells

Long-Term Follow-up of Hematopoietic Stem Cell Transplantation with the Modified Peking Regimen for the Treatment of Acute Leukemia

Dose-Adjusted Granulocyte Colony-Stimulating Factor Plus Dexamethasone Achieves More CD34+ Cell Mobilization and Earlier Engraftment in Haploidentical Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only